Group Versus Traditional Prenatal Care for Diabetes
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Oct 3, 2017
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Long term, the investigator aims to test the central hypothesis that group prenatal care, compared to traditional prenatal care, will improve, 1.) glycemic control and, 2.) postpartum weight retention in women with type 2 and gestational diabetes. The objective of this proposal is to conduct a randomized trial in two phases to determine the effect of Diabetes Group Care (GC) on glycemic control in pregnant women with T2DM and GDM (Antepartum Phase) and the impact on postpartum weight retention (Postpartum Phase).
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. English speaking
- 2. Type 2 diabetes OR gestational diabetes diagnosed by 2-step method(1) OR likely pre-existing Type 2 diabetes with one of the following during pregnancy and \</= 34 weeks:
- • 1. 1 hour glucose challenge test \>/= 185mg/dL OR
- • 2. A1c \>/= 6.5% OR
- • 3. Fasting plasma glucose \> 126mg/dL (2)
- • 3. Ability to attend group prenatal visit at specified days and times
- • 4. Willingness to be randomized at 22 weeks 0 days-34 weeks 0 days OR initial visit between 24 weeks 0 days-34 weeks 0 days
- • 5. Ability to give informed consent
- Exclusion Criteria:
- • 1. Prior participation in diabetes group care
- • 2. Type 1 Diabetes
- • 3. Multiple gestation
- • 4. Major fetal anomaly
- • 5. Serious medical co-morbidity necessitating more care than can be safely provided in group setting, as deemed by medical provider.
- • 6. Serious psychiatric illness including schizophrenia necessitating more care than can safely be provided in group setting, as deemed by medical provider.
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Patients applied
Trial Officials
Megan Lawlor, MD
Principal Investigator
Assistant Professor, Washington University in St. Louis
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials